APRIL BENTLEY: Open Payments
NPI 1871829044 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 28 payments from 11 companies in 2025. Trend: 2023 $14 · 2024 $1,634 · 2025 $845
Food & beverage: $845
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $233 |
| CVRx, Inc. | 1 | $192 |
| Abbott Laboratories | 1 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| Stryker Corporation | 1 | $70 |
| Amgen Inc. | 3 | $52 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $29 |
| Novo Nordisk Inc | 1 | $27 |
| BridgeBio Pharma, Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: LEQVIO, Barostim Neo System, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Kerendia, FLOWTRIEVER, REPATHA, LifeVest, Wegovy.
Industry payments across VA — which companies pay providers there.
